Clinical Trials in North Carolina

Showing 13821-13840 of 20,428 trials

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

NCT00430638

This 16 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients with moderate to severe high blood pressure in comparison to placebo. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Hypertension

Daiichi Sankyo278 participantsStarted Dec 2006

Birmingham, Alabama, United States • Mobile, Alabama, United States • Muscle Shoals, Alabama, United States +26 more locations

COMPLETEDPhase 241 miles

Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer

NCT00112489

RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving paclitaxel together with carboplatin works in treating patients with persistent or recurrent stage III or stage IV uterine cancer.

Sarcoma

Gynecologic Oncology Group55 participantsStarted May 2005

Birmingham, Alabama, United States • Los Angeles, California, United States • New Britain, Connecticut, United States +107 more locations

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer

Find Trials by Condition in North Carolina

Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD Device

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Phase II Combination Steroid and Anti-VEGF for Persistent DME

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Medical Therapy of Prostatic Symptoms

Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis